The results of the ATTAIN-2 study, which involved people with obesity or overweight and type 2 diabetes, showed that the oral ...

Eli Lilly stated that results from a late-stage trial of its pill variant of GLP-1 drugs met the requirements for global ...

GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study says Drug manufacturer Eli Lilly releases promising new data about its weight loss pill in clinica ...

Lilly said it plans to ask regulators to approve the drug by the end of 2025. View on euronews ...

With around 73 percent of Americans enjoying their daily coffee fix, it’s natural to wonder how your morning cup might ...

The TV presenter, 58, shared her concerns for 'impressionable young women' and said the endorsement was a 'betrayal of ...

A groundbreaking final stage trial showed users could lose more than 10 per cent of their weight after just over a year on ...

A growing number of patients claim popular weight loss and diabetes drugs like Ozempic can cause a rare but very serious side ...

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

FAT jabs have turned the tide on the obesity epidemic, but there’s a new challenge on the horizon – an obesity bounceback.

Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight in a late-stage trial, after recent data from another study of the drug in ...